COX-2蛋白和Survivin蛋白在人非小细胞肺癌组织中的表达及其临床意义(3)
 |
| 第1页 |
参见附件(2812KB，4页)。
[2] Onogawa S，Kitadai Y，Amioka T，et al.Expression of vascular endothelial growth factor(VEGF)-C and VEGF-D in early gastric carcinoma：correlation with clinicopathological parameters.Cancer Lett，2005，226(1)：85~90.
[3] Fontanini G，Vignati S，Lucchi M，et al.Neoangiogenesis and p53 protein in lung cancer：their prognostic role and their relation with vascular endothelial growth factor (VEGF) expression.Br J Cancer，1997，75(9)：1295~1301.
[4] Fontanini G，Calcinai A，Boldrini L，et al.Modulation of neoangiogenesis in bronchial preneoplastic lesions.Oncol Rep，1999，6(4)：813~817.
[5] Khuri FR，Wu H，Lee JJ，et al.Cyclooxygenase-2 overexpression is a marker of poor prognosis in stage I non-small cell lung cancer.Clin Cancer Res，2001，7(4)：861~867.
[6] Ochiai M，Oguri T，Isobe T，Ishioka S，Yamakido M.Cyclooxygenase-2(COX-2) mRNA expression levels in normal lung tissues and non-small cell lung cancers.Jpn J Cancer Res，1999，90(12)：1338~1343.
[7] Han SL，Tang HJ，Hua YW，Ji SQ，Lin DX.Expression of COX-2 in stomach cancers and its relation to their biological features.Dig Surg，2003，20(2)：107~114.
[8] Monzo M，Rosell R，Felip E，et al.A novel anti-apoptosis gene：Re-expression of survivin messenger RNA as a prognosis marker in non-small-cell lung cancers.J Clin Oncol，1999，17(7)：2100~2104.
[9] Jiang G，Li J，Zeng Z，Xian L.Lentivirus-mediated gene therapy by suppressing survivin in BALB/c nude mice bearing oral squamous cell carcinoma.Cancer Biol Ther，2006，5(4)：435~440.
[收稿 2009-02-12]
注：本文中所涉及到的图表、注解、公式等内容请以PDF格式阅读原文
您现在查看是摘要介绍页，详见PDF附件(2812KB，4页)。